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dn this issue of iJACC, a large validation series of
the prognostic value of significant coronary ar-
tery disease (CAD) by cardiac computed tomo-
graphic angiography (CTA) is published (1).
his new report adds to our understanding of the
rognostic accuracy of CTA measurements of ob-
tructive CAD for risk stratification purposes by
ncluding a large consecutive series of 1,667 pa-
ients. Placing this data within the context of ex-
sting CTA data, we observe improved precision
n risk stratification and an obvious separation in
vents between patients with none-mild CAD
ompared to those with obstructive CAD. The
ummary meta-analytic rate for obstructive CAD
s more than 10-fold higher than that of patients
ith none-mild CAD.
When comparing risk stratification with CTA
o that of other imaging modalities, interesting
atterns illumine a direction for future develop-
ents for this modality (Fig. 1) (2–10). The sum-
ary meta-analytic rate for obstructive CAD is
igher (11.1%, 5.1% to 22.5%) than for that of
ignificant perfusion (6.2%, 5.9% to 6.5%) or in-
ucible wall motion (7.5%, 5% to 13.4%) abnor-
alities; highlighting the importance of the bur-
en of CAD as the prominent driver for
nfluencing the hazard for cardiovascular events.
or CTA, more extensive, severe, and proximal
ocation of obstructive CAD defines higher CAD
vent rates (11,12). The totality of interaction of
bstructive CAD with ischemia as a modulator of
isk is unclear. Further the degree to which over-
ap exists between extensive CAD and severea
rom *Emory University, Atlanta, Georgia; and the †University of
alifornia-Irvine, Irvine, California.schemia is also unclear but remains an important
oal for future developments in risk stratification,
hich will also focus on the interplay between
onischemic CAD to ischemic mild to severe
AD.
CTA has tremendous potential due to its abil-
ty to define not only obstructive CAD but to ex-
mine the burden of nonobstructive atherosclero-
is. By examining the current evidence, the
ummary CAD event rate for CTA-verified
one-mild CAD (1.5%, 0.9% to 2.6%) is decid-
dly higher when compared to that of no perfu-
ion abnormalities (0.6%). The higher event rate
ith no obstructive CAD on CTA indicates a
hreshold of risk for significant stenosis (. . .or
ore extensive atherosclerotic disease) that is
igher than that for nonobstructive CAD. This
hreshold needs to be addressed to define the im-
ortance/characteristics of nonobstructive athero-
clerosis. An example of this is the very low event
ate in individuals with a zero coronary artery cal-
ium score (13,14). A gradient of cardiovascular
vent risk occurs directly proportional to the ex-
ent of calcification (13,14). The lack of correla-
ion between obstructive CAD and coronary cal-
ium, yet its important risk stratification ability,
dentifies the significant risk burden of nonob-
tructive atherosclerosis. To that end, one can en-
ision even lower event rates for CTA nonob-
tructive CAD declining from mild coronary
esions, on the high end of this 1.5% event rate,
o a very low-risk for those with no plaque, more
losely approximating population norms for risk.
Similar to the role of obstructive CAD in
efining higher risk status, the characteristics ofnonobstructive plaque should modulate the
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525isk spectrum. We have yet to clearly define the
raded change in risk with nonobstructive ath-
rosclerosis that occurs below the obstructive
AD threshold. Additionally, within the non-
bstructive atherosclerotic disease subsets, fea-
ures of high-risk plaque may proffer a substan-
ial risk for downstream acute coronary
yndromes (ACS). Preliminary evidence sug-
ests that certain plaque characteristics may be
efinable with CTA and provide an important
ink to ACS risk including sudden death (15).
ovel gains in risk detection may be realized
ithin nonobstructive atherosclerotic disease
ubsets to define unique subsets whose risk is
quivalent to those with obstructive CAD. The
efining of CAD risk equivalent status patients,
ay blur the prominence of symptoms, obstruc-
ive disease or perfusion deficit as signifying
isk, but identify risk gradation that occurs
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Figure 1. Meta-Analyses of the 1-Year Event Rates
One-year event rates (95% conﬁdence intervals) are presented for n
nary computed tomography angiography (CTA), and for normal and
puted tomography (SPECT) and positron emission tomography (PET
echocardiography (9,10). The event rates are calculated using a ran
obstructive and obstructive CAD (p  0.0001). Event types are varie
and/or revascularization.cross the spectrum of nonobstructive and ob- Etructive CAD. Thus, future developments in
he field of CTA should focus on improving
he granularity of lower and higher risk status
ncluding modulation of ischemic risk. A better
nderstanding of the role of CTA in risk de-
ection is fundamental to integrating this mo-
ality into every day clinical decision making.
ur mandate for the future of cardiac imaging
s now to devise strategies to improve the cur-
ent detection gap that afflicts millions of pa-
ients annually in this country and worldwide.
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bstructive and obstructive coronary artery disease (CAD) by coro-
normal stress myocardial perfusion single-photon emission com-
ta are compiled for SPECT (2), for PET (3,4), and for
effects model with signiﬁcant heterogeneity noted for no
y study including death, myocardial infarction, unstable angina,ativ
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